Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up

Status Completed

Clinical Trial Summary

This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system.

Clinical Trial Description

Females under age 18 years old are the fastest-growing segment of the juvenile justice population and are at risk for negative co-occurring outcomes including drug abuse, HIV/STI risk, criminal behavior, and educational failure. As they enter young adulthood, this constellation of behaviors puts them at heightened risk for early parenthood and subsequent involvement in the child welfare system (for their parenting behaviors) and the adult corrections system (for criminal behaviors). Such system involvement is costly, and its prevention would be of great significance to public health; however, very little is known about factors leading to females' success/failure in young adulthood and factors that might prevent involvement in these two public systems. This study aims to further our understanding of the pathways to and the prevention of HIV/STI risk, drug use, and child welfare and adult corrections involvement by following-up 166 women who participated in two randomized intervention trials aimed at reducing delinquency during adolescence. In the original studies, juvenile justice girls who had been referred for out-of-home placement due to chronic delinquency were randomly assigned to services as usual or to Treatment Foster Care Oregon (TFCO, formerly known as MTFC). Efficacy of the intervention with this sample has been shown at 12- and 24-month follow-ups on criminal referral rates, days spent in locked settings, deviant peer associations, educational engagement, and pregnancy prevention. The investigators propose to examine the developmental pathways for these juvenile justice girls into young adulthood (ages 21-28 years) using innovative data collection and data analytic techniques, with foci on the long-term effects of TFCO, the mediators of young adult adjustment and child welfare/corrections involvement, and the cost effectiveness and cost avoidance of TFCO on these outcomes. The overarching aim is to identify potential targets for subsequent intervention. One in-person assessment is proposed with each female and her current romantic partner (if she has one); in addition, telephone interviews will be conducted every 6 months for the duration of the study, and system data from child welfare and adult corrections will be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01341626
Study type	Interventional
Source	Oregon Social Learning Center
Contact
Status	Completed
Phase	N/A
Start date	January 1997
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05468879` - Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects	N/A
Not yet recruiting	`NCT06395129` - Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Completed	`NCT02293057` - Gender-Responsive Drug Use Treatment for Juvenile Justice Girls	N/A
Completed	`NCT01941108` - Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care	N/A
Completed	`NCT01380613` - Neighborhoods, Networks, Depression, and HIV Risk	Phase 2
Withdrawn	`NCT00914719` - Alcohol Use and Sexual Risk: An Intervention	N/A
Recruiting	`NCT03671629` - Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly	N/A
Completed	`NCT03290391` - Linking Infectious and Narcology Care-Part II	Phase 4
Completed	`NCT04008927` - A Community-based Intervention Among Active Drug Users in Montpellier	N/A
Completed	`NCT03627546` - HCV Seek, Test and Rapid Treatment for Young PWID	N/A
Not yet recruiting	`NCT03967262` - Secondary Prevention and Recidivism Reduction in Trauma Patients	N/A
Completed	`NCT03079856` - Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER	N/A
Completed	`NCT03855410` - Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention	N/A
Terminated	`NCT02457949` - The Impact of Alternative Social Assistance Disbursement on Drug-related Harm	N/A
Completed	`NCT06238154` - Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds	Phase 4
Terminated	`NCT04436055` - Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
Recruiting	`NCT04717856` - Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA	N/A
Completed	`NCT00249496` - Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1	N/A
Recruiting	`NCT05597865` - Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents	N/A
Completed	`NCT05553054` - Drug Wastage : Observational Study in Intensive Care Units in France

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.